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Abstract 
 
 
 
A two step synthesis of carboxy functionalized planar chiral [2.2]metacyclophanes from m-xylenes 
is described. Both transformative steps utilize LiNK metalation conditions (BuLi, KOtBu, TMP(H)) 
for m-xylene benzylic deprotonation with subsequent in situ oxidative C-C coupling.  Inclusion of 
the carboxy substituents at either C4 or C4 and C14 renders the [2.2]metacyclophanes planar 
chiral and the structural analysis of both substitution patterns has been achieved with X-ray 
crystallography and NMR. The C4 mono and C4/14 di-substituted carboxylic acid methyl ester 
racemates were readily separated by analytical and preparative chiral HPLC and their inversion 
barriers measured in heptanes at 373 K are 32.3 kcal/mol and 31.1 kcal/mol respectively. The 
facile synthesis, separation and sufficiently high inversion barriers of the [2.2]metacyclophane 
planar chiral class warrant their investigation as potential planar chiral catalysts and ligands which 
to date has yet to be explored. 
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Introduction 
The unique and intriguing properties of constrained [2.2]cyclophanes has lead to a continued 
interest in them since the first report of Brown and Farthing in 1949.1 “Phane” molecules combine 
the interactions between layered π-systems within constrained three-dimensional architecture, 
and this unique feature has been extensively exploited and developed leading to a widely variable 
class of chiral molecules successfully employed in stereoselective synthesis.2 In this context the 
para-[2.2]paracyclophanes have seen a recent resurgence of interest notably as planar chiral 
scaffolds for asymmetric catalysis.3 Among the other potential chiral cyclophane structures, the 
planar chirality of [2.2]metacyclophanes has received scant attention, with the synthesis of only a 
few chiral derivatives haven been described.4  Thermodynamic and kinetics studies have shown 
that for the [n.n]metacyclophanes, only the most constrained [2.2]metacyclophanes have an 
inversion barrier (torsional barrier) high enough to permit resolution of conformationally stable 
enantiomers.5 However, only few examples of optical resolution4a,6 and crystal structure 
determinations7 of planar chiral [2.2]metacyclophanes have been reported to date.  
We recently reported that challenging benzylic metalations can be achieved with excellent 
regioselectivity by means of the mixed Li/K metal TMP amide (LiNK metalation conditions) 
generated in situ by the reagent triad BuLi/KOt-Bu/TMP(H).8 In the course of our studies aimed to 
exploit further synthetic applications of LiNK metalation conditions, we described a new two-step 
general approach to [2.2]metacyclophanes starting from cheap commercially available substituted 
m-xylenes.9 Our strategy employs a selective benzylic metalation with an in situ oxidative coupling 
reaction10 for both synthetic operations under LiNK metalation conditions. The synthetic 
usefulness of this approach prompted us to expand our approach to the synthesis of planar chiral 
[2.2]cyclophane derivatives. In order to render the [2.2]metacyclophane scaffold planar chiral, the 
symmetry plane bisecting the cyclophane ring must be differentiated by substitution in either 
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positions C-4 or C-4 and C-14 (Figure 1), which renders the original C2 symmetry lost and planar 
chirality is created. In this report the synthesis, structural characterization, enantiomer separation 
and stability analyses of potentially useful optically active mono- and di-
carboxy[2.2]metacyclophanes are described. 
 
 
Figure 1. Planar Chiral [2.2]metacyclophanes 
 
Results and Discussion 
The preparation of planar chiral carboxy[2.2]metacyclophanes derivatives has already been 
described in the literature resorting to multi-steps synthetic approaches. The synthesis of 
[2.2]metacyclophane-4,14-dicarboxylic acid 5 has been previously accomplished by conversion of 
the corresponding dimethyl derivative, which has been obtained as a mixture with the 4,12- isomer 
after stereoselective chloromethylation of toluene followed by Wurtz coupling.11 Bromomethylation 
and subsequent Sommelet reaction led to the corresponding dialdehyde derivative which has been 
finally oxidized to the target compound 5.11 Similarly, the monosubstituted 4-carboxylic acid 8 has 
been prepared by an elaborated 7-steps synthesis.4a In this case, the metacyclophane skeleton was 
built by alkylation of lithiated isophthalaldehyde bis-dithiane with 1-bromo-2,4-dibromobenzene 
followed by reductive cleavage of dithiane with Raney Ni catalyst. Treatment of the resulting 4-
bromo[2.2]metacyclophane with diazomethane followed by basic hydrolysis led to the 
corresponding carboxylic acid 8. Both mono- and bis-carboxy racemic mixtures of 5 and 8 where 
resolved via their diastereomeric salts with (+)-1-phenylethylamine.4a,12 
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LiNK metalation conditions with in situ oxidative coupling offers a facile general approach to the 
[2.2]metacyclophanes.9  Using this strategy access to carboxy substituted planar chiral derivatives is 
possible from the two inexpensive starting material m-xylene and 2,4-dimethylbenzoic acid.  Using 
these two reagents the planar chiral C-4 carboxy and C-4/14 di-carboxy substituted derivatives 
could be synthesized which could viewed as bench mark examples of this planar chiral scaffold.  
On the basis of our previously reported results on the thermodynamically controlled selective 
metalation of 2,4-dimethylbenzoic acid 1 under LiNK conditions (90% D incorporation in the more 
acidic 2-position),9 a two step metalation/coupling sequence to achieve the desired 
[2.2]metacylophane-4,14-dicarboxylic acid 5 was carried out (Scheme 1). Treatment of 1 with 2 
equivalents of BuLi (one for the deprotonation of the carboxylic group) and 1 equivalent of KOt-Bu 
and TMP(H) in THF at 78 °C for 15 min led to the dianion 2, which underwent oxidative 
homocoupling after addition of 1,2-dibromoethane at 78 °C leading to the corresponding 2,2'-
(ethane-1,2-diyl)bis(4-methylbenzoic acid) 3 in 82% yield. In order to assess the di-benzylic 
metalation of 3 a deuteration study was first carried out prior to attempting the cyclophane 
formation via ring closure step. The resulting homo-dimer product represented a challenging 
substrate for a subsequent benzylic di-metalation due to the formation of a tetra-anionic 
intermediate 4. Upon metalation of 3 with LiNK conditions of 4:2:2 equivalences of BuLi:KOt-
Bu:TMP(H) at 78 °C for 15 min and quenching with CD3OD, 2H NMR showed that selective 
deuterium incorporation into both benzylic positions had been achieved to give 3-D2 without any 
aryl deuteration detected.  To effect ring closure to the cyclophane metalation was repeated to 
provide the tetra-anion 4 which was oxidatively ring closed with 1,2-dibromoethane leading to 5rac 
in 35% yield after purification. The product was subsequently converted to the corresponding 
[2.2]metacyclophane-4,14-dicarboxylic acid dimethyl ester 6rac with MeOH/HCl which was 
isolated pure following column chromatography. 
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Scheme 1:  Iterative LiNK/oxidative coupling synthesis of [2.2]metacyclophane-4,14-dicarboxylic 
acid 5 and corresponding dimethyl ester 6. 
 
In a similar way, we have previously shown that LiNK di-benzylic metalation of substrate 7 and 
oxidative ring closure generates the planar chiral 4-carboxylic acid substituted metacyclophane 8 
(Scheme 2).9  Purification of the crude reaction mixture was easily achieved by column 
chromatography giving 8 in 39% yield as a racemic mixture.  Esterification of carboxylic acid 8rac 
was carried out in MeOH/HCl under reflux to provide cyclophane 9rac in a quantitative yield.  
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Scheme 2:  LiNK / oxidative coupling synthesis of 4-carboxy-[2.2]metacyclophanes 8 and 9. 
 
In anticipation of future investigations into the ability of metacyclophanes to act as chiral catalysts 
and ligands efforts were made to obtain solid state structures and high resolution NMR data for 6, 8 
and 9 as little of such data has been previously reported.  Metacyclophane 6 was crystallized by the 
slow room temperature evaporation of a diethyl ether solution into the orthorhombic space group 
Pna21,
13 and analysis of the X-ray crystal structure with characteristic 1H NMR data collected at 
500 MHz are summarized in Table 1. 
 
Table 1:  Crystal Structure and relevant NMR data for 6 
 
Entry  Measurement Data 
1 Intra-annular distance (C8 to C16) 2.66(1) Å 
2 A ring distortion from planarity 7.7(1)° 
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3 B ring distortion from planarity 7.7(4)° 
4 Bond length C1-C2 1.574(2) Å 
5 Angle C1-C2-C3 109.94(12)° 
6 Torsion angle C3-C4-C18-O1 2.2(3)° 
7 Torsion angle C15-C14-C20-O3 9.5(2)° 
8 Ha/Ha' chemical shifta 4.27 ppm 
9 Hb/Hb' chemical shifta 1.96 ppm 
10 He/He' chemical shifta 4.37 ppm 
a in CDCl3 
 
The X-ray structure confirmed the expected stepwise anti conformation typical of the 
[2.2]metacyclophane scaffold.14  The characteristic geometrical feature of a strained 
metacyclophane is the out of plane bending of the aromatic rings into a boat conformation,5b 
represented for diester 6 with a deviation from planarity of 7.7(1)° and 7.7(4)° for A and B rings 
respectively (Table 1, entries 2 and 3). Its central ten-membered ring adopts a chair-like 
conformation, where the two aromatic rings sit in parallel planes as confirmed by the high 1H NMR 
shielding of the two equivalent He aromatic protons at 4.37 ppm (entry 10). Thus, the closest 
approach of the two benzene rings to one another is 2.66(1) Å, as measured from the C8 of A ring 
to the C16 of the other ring (entry 1). The bond length (1.574(2) Å) of the cavity measured from C1 
to C2 (entry 4) together with the bond angle C1-C2-C3 of 109.94(12)° (entry 5) further confirm the 
shortness of the bridge and its effect on the ring strain and conformational rigidity of the molecular 
framework. Noteworthy is the orientation of the two carboxy methyl groups which adopt a co-
planar conformation compared to the aromatic rings, with a torsion angle C3-C4-C18-O1 of 
2.2(3)° for the A ring (entry 6) and C15-C14-C20-O3 of 9.5(2)° for the B ring (entry 7) 
respectively. The two carbonyl groups C18-O1 and C20-O3 are thus aligned facing to the bridge 
protons Ha and Ha', which is confirmed in solution by 1H NMR deshielding effect of 4.27 ppm for Ha 
9 
 
and upfield shift of 1.96 ppm for Hb (entries 8 and 9) compared to the more shielded Hc and Hd 
nuclei (Δδ Hc/d = 1.08 ppm) sited on the non-substituted face of the molecule. 
 
The C-4 carboxylic substituted metacyclophane 8 was also crystallized at room temperature from an 
acetone solution into the triclinic space group P-1,15 with a summary of the X-ray crystal and 1H 
NMR data shown in Table 2. 
 
Table 2:  Crystal Structure and relevant NMR data for 8 
 
Entry  Measurement Data 
1 Intra-annular distance (C8 to C16) 2.63(8) Å 
2 A ring distortion from planarity 7.7(3)° 
3 B ring distortion from planarity 7.2(4)° 
4 Bond length C1-C2 1.569(3) Å 
5 Angle C1-C2-C3 110.54(15)° 
6 Torsion angle C3-C4-C18-O1 16.6(3)° 
7 Ha chemical shifta 4.38 ppm 
8 Hb chemical shifta 1.86 ppm 
9 He chemical shifta 4.36 ppm 
10 He' chemical shifta 4.33 ppm 
a in CDCl3 
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The overall geometrical features of the metacyclophane 8 motif reflect the same architecture of the 
diester 6, with a small ten-member ring cavity defined by a methylene bridge of 1.569(3) Å 
measured from C1 to C2, a bond angle of 110.54(15)° and the intra-annular distance of 2.63(8) Å 
(Table 2, entries 1, 4-5). The crystal structure shown again the parallel alignment of the two non-
planar aromatic rings (entries 2 and 3) reflected in the 1H NMR shielding of the two non equivalent 
He and He' protons (entries 9 and 10).  The carboxylic group has a small torsion angle of 16.6(3)° 
for C3-C4-C18-O1 (entry 6), causing an alignment of the CO group with the C2 bridge protons Ha. 
This could be attributed to the significant difference in chemical shift (Δδ of 2.52 ppm) observed for 
equatorial Ha and axial Hb 
1H NMR signals (entries 7 and 8) in CDCl3. The unit cell contains both 
enantiomers forming hydrogen bonded chains with a typical OH length of 1.79(9) Å (Figure 2). 
 
 
Figure 2.  H-bonded chains (top) and unit cell (bottom) of X-ray structure 8 
 
The spatial arrangement of the carboxylates groups into the 4- and 14- positions of the aryl rings is 
noteworthy, as the anti stepwise conformation of the metacyclophane scaffold presents the two 
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Bronsted acid functional groups in a unique manner.  As shown in the frontal view of their X-ray 
structures, both derivatives 6 and 9 show a differentiation of the two sides of the molecules with 
respect to the vertical plane bisecting the metacyclophane ring (Figure 3, left). The carboxylate 
groups are pointing toward one side defining coordinating site(s) of the molecule, with the other 
side behaving as the chiral discriminator.  Uniquely, the stepwise conformation may offer a 
potential chiral environment in an asymmetric transformation. Moreover, in the case of the 
disubstituted derivative 6, the staggered conformation of the two aromatic rings arranges the 
functional groups into different planes (with a distance of 5.34 Å as measured from the two 
carbonyl sites), thus defining two potentially independent reactive sites on the same chiral 
scaffold (Figure 3, right).  
Cyclophane 6 
 
 
Cyclophane 8 
 
 
Figure 3.  Front view (left) and side view (right) of X-ray structures 6 and 8 
 
The racemic mixtures of methyl esters 6 and 9 were analyzed by analytical chiral HPLC under 
normal phase conditions, showing good to excellent separations on four different chiral stationary 
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phases (Figure 3). Racemates 6 and 9 were then resolved by semi-preparative chiral HPLC using a 
Chiralcel OD column, and the absolute configuration of pure enantiomers was assigned by 
comparison of the optical rotation with literature data.6b,12 
 
 
 
Figure 3.  Chiral HPLC separation of 6 (top) and 9 (bottom) over Chiralpak IA (black), Chiralpak 
IB (red), Chiralpak AS-H (blue) and Chiralcel OJ-H (green) columns.  
 
Finally, enantiopure samples of esters 6 and 9 were subjected to racemization by heating in 
heptanes at 373 K or in N-methyl-2-pyrrolidone at 453 K and monitoring the course of the reaction 
by analytical chiral HPLC.  
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Figure 4.  Racemization plots of esters 6 (blue) and 9 (green) in heptanes at 373 K. 
 
Since the racemization process interconverts enantiomers via a reversible first-order reaction, the 
inversion barriers were calculated on the basis of the absolute rate equation16 from the values of the 
rate constants determined via a first-order integrated law plot (Figure 4). From our racemization 
study on optically active cyclophanes 6 and 9 we found values for the inversion of the ten-
membered ring of 31.1 kcal/mol and 32.3 kcal/mol respectively. Similar values (33.3 kcal/mol and 
33.5 kcal/mol) were obtained in NMP at 453 K.  Our racemization rates are consistent with those 
calculated in by Schlogl in 1974,5a confirming that while the inversion barriers are dependent on the 
length of the bridge,17 the value is not affected by substituents on the aryl rings and therefore 
corresponds to the value of unsubstituted [2.2]metacyclophane scaffold.5b  These values compare 
favorably with [2.2]paracyclophanes (37.8 kcal/mol) where the relatively high torsional barriers 
have been explained by a mechanism involving bond breaking to give achiral benzyl radicals as 
intermediates.18 
 
Conclusion 
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In summary a two step synthesis of the planar chiral [2.2]metacyclophane framework containing 
one or two carboxy functional groups at the key C-4/14 positions utilizing LiNK metalation and 
oxidative C-C bond formation has been described. The planar chiral derivatives have been 
characterized by X-ray crystallography and NMR, and the racemic mixtures separated by chiral 
HPLC. The ease of enantiomer separation and the relatively high inversion barrier to racemization 
indicates their potential as planar chiral catalysts and ligands which to date has not been explored. 
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Experimental Details 
General Methods: All reactions involving air-sensitive reagents were performed under nitrogen in 
oven-dried glassware using syringe-septum cap technique. All solvents were purified and degassed 
before use. Chromatographic separations were carried out under pressure on Merck silica gel 60 
using flash-column techniques. Reactions were monitored by thin-layer chromatography (TLC) 
carried out on 0.25 mm silica gel coated aluminum plates (60 Merck F254) with UV light (254 nm) 
as visualizing agent. Unless specified, all reagents were used as received without further 
purifications. TMP(H) was distilled from CaH2 prior to use and THF was obtained from a solvent 
purification system. BuLi was purchased as a 2.5 M solution in hexanes. KOt-Bu was purchased as a 
1 M solution in THF. The exact concentration of the organolithium solution was determined by 
titration with diphenylacetic acid in THF prior to use.19 1H NMR and 13C NMR spectra were 
recorded at room temperature at 500 MHz and 100 or 125 MHz respectively and calibrated using 
residual undeuterated solvent as an internal reference. 2H NMR (92.07 MHz) spectra were 
obtained in DMSO using residual DMSO-d6 as an internal standard. Compound 7 was synthesized 
as previously reported.9 Optical rotations were measured at 589 nm. Analytical chiral HPLC 
analyses were performed on Daicel Chiralpak and Daicel Chiralcel series columns (250 x 4.6 mm 
ID) using heptane/ethanol as solvent mixtures. Semi-preparative HPLC analyses were carried out 
on a Daicel Chiralcel OD column (250 x 20 mm ID) using heptane/2-propanol as solvent mixtures. 
 
2,2'-(Ethane-1,2-diyl)bis(4-methylbenzoic acid) (3).20 A solution of 2,4-dimethylbenzoic acid 1 
(451 mg, 3.00 mmol) in THF (15 mL) at −78 C was treated dropwise with BuLi (2.40 M, 2.63 mL, 
6.30 mmol) and stirred for 5 min. KOtBu (1.0 M in THF, 3.30 mL, 3.30 mmol) was added dropwise 
followed by 2,2,6,6-tetramethylpiperidine (0.56 mL, 3.30 mmol). The reaction mixture was stirred 
for 15 min at −78 C and 1,2-dibromoethane (0.77 mL, 9.00 mmol) added. The reaction mixture 
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was warmed to rt and the solvent removed under reduced pressure. Ethyl acetate (30 mL) was 
added to the residue, washed with HCl (2 M, 3 x 10 mL), dried over sodium sulphate and 
concentrated to dryness. Trituration from diethyl ether with cooling gave 3 as a white solid (367 
mg, 82%), mp 287-288 °C (lit.20 mp 289 °C). 1H NMR (500 MHz, DMSO-d6): δ 12.65 (bs, 2H), 7.74 (d, 
J = 8.4 Hz, 2H), 7.17-7.03 (m, 4H), 3.13 (s, 4H), 2.32 (s, 6H). 13C NMR (125 MHz, DMSO-d6): δ 169.0, 
143.7, 142.1, 131.7, 131.0, 127.7, 127.1, 36.1, 21.4. HRMS [M-H]+: 297.1115, C18H17O4 requires 
297.1127.  
 
2,2'-(Ethane-1,2-diyl)bis(4-(deuteriomethyl)benzoic acid) (3-D2). A solution of 2,2'-(ethane-1,2-
diyl)bis(4-methylbenzoic acid) 3 (60 mg, 0.20 mmol) in THF (10 mL) at −78 C was treated dropwise 
with nBuLi (2.50 M, 0.33 mL, 0.82 mmol) and stirred for 5 min. KOt-Bu (1.0 M in THF, 0.42 mL, 0.42 
mmol) was added dropwise followed by 2,2,6,6-tetramethylpiperidine (71 µL, 0.42 mmol). The 
reaction mixture was stirred for 15 min at −78 C and CD3OD (33 µL) added. The reaction mixture 
was warmed to rt and the solvent removed under reduced pressure. Ethyl acetate (20 mL) was 
added to the residue, washed with HCl (2 M, 3 x 10 mL), dried over sodium sulphate and 
concentrated to dryness to gave 3-D2 as a white solid (51 mg, 84%; 80% D incorporation). 1H NMR 
(500 MHz, DMSO-d6): δ 7.81-7.69 (m, 2H), 7.17-7.06 (m, 4H), 3.17-3.06 (m, 4H), 2.30 (s, 2H), 2.28 
(s, 2H). 13C NMR (125 MHz, DMSO-d6): δ 169.0, 143.7, 142.1, 131.7, 131.0, 127.7, 127.1, 36.1, 21.4 
(t, J = 19.5 Hz). 2H NMR (92.07 MHz, DMSO): δ 2.29 (s). HRMS [M]+: 300.1320, C18H16D2O4 requires 
300.1331.  
 
[2.2]Metacyclophane-4,14-dicarboxylic acid (5).11 A solution of 2,2'-(ethane-1,2-diyl)bis(4-
methylbenzoic acid) 3 (241 mg, 0.81 mmol) in THF (25 mL) at −78 °C was treated dropwise with 
BuLi (2.26 M, 1.47 mL, 3.32 mmol) and stirred for 5 min. KOt-Bu (1.0 M in THF, 1.70 mL, 1.70 
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mmol) was added dropwise followed by 2,2,6,6-tetramethylpiperidine (0.29 mL, 1.70 mmol). The 
reaction mixture was stirred for 30 min during which time the temperature was raised to −60 °C. 
Afterwards 1,2-dibromoethane (0.16 mL, 2.43 mmol) was added, the reaction mixture was 
warmed to rt and the solvent was removed under reduced pressure. Diethyl ether (30 mL) was 
added to the residue and the diacid was extracted by aqueous NaOH (2 M, 20 mL). The basic 
solution was washed twice with diethyl ether and acidified to pH=1 with HCl (2 M, 40 mL). The 
diacid was then extracted with DCM (3 x 30 mL), the organic phase was dried over sodium 
sulphate and concentrated to dryness. Purification by filtration over a short silica gel plug eluting 
with 100:0 to 90:10 DCM:MeOH gave 5 as a white solid (Rf = 0.10, 83 mg, 35%), mp >350 °C. 1H 
NMR (500 MHz, CD3OD) δ 7.93 (d, J = 7.8 Hz, 2H), 7.16 (dd, J = 7.8, 1.4 Hz, 2H), 4.37-4.31 (m, 2H), 
4.29-4.22 (m, 2H), 3.24-3.14 (m, 2H), 2.14-2.04 (m, 2H), 1.94-1.83 (m, 2H). 13C NMR (100 MHz, 
CD3OD): δ 169.9, 142.5, 140.3, 137.3, 131.3, 125.0 (2C), 40.1, 37.8. HRMS [M-H]+: 295.0981, 
C18H15O4 requires 295.0970. 
 
[2.2]Metacyclophane-4,14-dicarboxylic acid dimethyl ester (6).4c A solution of 
[2,2]metacylophane-4,14-dicarboxylic acid 5 (47 mg, 0.16 mmol) in methanol (20 mL) was acidified 
with 12 M HCl (three drops) and heated under reflux for 16 h. The solvent was removed under 
reduced pressure and ethyl acetate (20 mL) was added. The organic layer was washed with 
saturated NaHCO3 and water, dried over sodium sulphate and concentrated to dryness. 
Purification by silica gel chromatography eluting with 80:20 cyclohexane:diethyl ether gave 6 as a 
white solid (Rf = 0.70, 4.9 mg), mp 138-139 °C (lit.4c mp 138-140 °C). 1H NMR (500 MHz, CDCl3) δ 
7.94 (d, J = 7.9 Hz, 2H), 7.13 (dd, J = 7.9, 1.6 Hz, 2H), 4.38-4.36 (m, 2H), 4.31-4.22 (m, 2H), 3.93 (s, 
6H), 3.23-3.14 (m, 2H), 2.14-2.06 (m, 2H), 2.01-1.92 (m, 2H). 13C NMR (100 MHz, CDCl3): δ 168.1, 
142.4, 140.7, 137.7, 131.5, 126.6, 125.3, 51.9, 40.6, 38.2. HRMS [M+H]+: 325.1456, C20H21O4 
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requires 325.1440. [α]D20 = +77.5 (c 0.2, ethanol) and [α]D20 = 76.7 (c 0.2, ethanol) after chiral 
semi-preparative HPLC. Analytical chiral HPLC analysis of the racemic mixture (254nm UV detector, 
room temperature, eluent: 2% ethanol in heptane, flow rate: 1.0 mL/min):  
Daicel Chiralpak IA: t1 = 9.2 min  and  t2 = 14.5 min  
Daicel Chiralpak IB:  t1 = 6.3 min  and  t2 = 7.4 min 
Daicel Chiralpak AS-H: t1 = 6.3 min  and  t2 = 7.5 min 
Daicel Chiralcel OJ-H: t1 = 14.0 min  and  t2 = 19.6 min 
 
[2.2]Metacyclophane-4-carboxylic acid (8).4a A solution of 4-methyl-2-(3-
methylphenethyl)benzoic acid 7 (117 mg, 0.460 mmol) in THF (10 mL) at −78 C was treated 
dropwise with BuLi (2.50 M, 0.61 mL, 1.52 mmol) and stirred for 5 min. KOt-Bu (1.0 M in THF, 1.01 
mL, 1.01 mmol) was added dropwise followed by 2,2,6,6-tetramethylpiperidine (0.17 mL, 1.01 
mmol). The reaction mixture was stirred for 30 min during which time the temperature was raised 
to –60 °C. Afterwards 1,2-dibromoethane (0.12 mL, 1.38 mmol) was added, the reaction mixture 
was warmed to rt and the solvent removed under reduced pressure. Ethyl acetate (20 mL) was 
added to the residue, washed with HCl (2 M, 3 x 10 mL), dried over sodium sulphate and 
concentrated to dryness. Purification by silica gel chromatography eluting with 1:1 
cyclohexane:diethyl ether gave 8 as a white solid (Rf = 0.55, 46 mg, 39%), mp 192-196 °C (lit.4a mp 
197-199 °C). 1H NMR (500 MHz, CD3OD): δ 7.83 (d, J = 7.9 Hz, 1H), 7.21 (t, J = 7.5 Hz, 1H), 7.06 (dd, 
J = 7.9, 1.4 Hz, 1H), 7.06-6.92 (m, 2H), 4.21 (s, 1H), 4.18 (s, 1H), 4.15 (dt, J = 11.9, 3.6 Hz, 1H), 3.09-
3.04 (m, 2H), 3.01 (dt, J = 12.2, 3.6 Hz, 1H), 2.10 (td, J = 12.2, 3.1 Hz, 1H), 2.04-1.93 (m, 2H), 1.70 
(td, J = 11.9, 3.1 Hz, 1H). 13C NMR (125 MHz, CDCl3): δ 172.0, 144.4, 141.4, 139.3, 138.6, 138.6, 
138.1, 135.8, 132.2, 129.3, 125.8, 125.6, 125.3, 41.0, 40.7, 40.3, 39.2. HRMS [M-H]+: 251.1078, 
C17H15O2 requires 251.1072. 
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[2.2]Metacyclophane-4-carboxylic acid methyl ester (9).4a A solution of [2,2]metacylophane-4-
carboxylic acid 8 (22 mg, 0.09 mmol) in methanol (10 mL) was acidified with 12 M HCl (three 
drops) and heated under reflux for 16 h. The solvent was removed under reduced pressure and 
ethyl acetate (20 mL) was added. The organic layer was washed with saturated NaHCO3 and water, 
dried over sodium sulphate and concentrated to dryness. Purification by silica gel chromatography 
eluting with 90:10 cyclohexane:ethyl acetate gave 9 as a white solid (Rf = 0.80, 18 mg, 75%), mp 
68-70 °C (lit.4a mp 71-73 °C). 1H NMR (500 MHz, CDCl3): δ 7.92 (d, J = 7.9 Hz, 1H), 7.31 (t, J = 7.5 Hz, 
1H), 7.13-7.04 (m, 3H), 4.32 (s, 1H), 4.30 (s, 1H), 4.22 (dt, J = 11.9, 3.6 Hz, 1H), 3.92 (s, 3H), 3.19-
3.10 (m, 3H), 2.24 (td, J = 12.3, 3.2 Hz, 1H), 2.15-2.05 (m, 2H), 1.84 (td, J = 11.9, 3.3 Hz, 1H). 13C 
NMR (125 MHz, CDCl3): 168.1, 143.3, 140.5, 139.3, 138.4, 138.1, 135.9, 131.1, 129.2, 126.2, 125.8, 
125.4, 125.3, 51.8, 40.9, 40.7, 40.2, 39.0. HRMS [M]+: 266.1299, C18H18O2 requires 266.1307. [α]D20 
= +5.5 (c 0.5, CHCl3) and [α]D20 = 6.0 (c 0.5, CHCl3) after chiral semi-preparative HPLC. Analytical 
chiral HPLC analysis of the racemic mixture (254nm UV detector, room temperature, eluent: 0.2% 
ethanol in heptane, flow rate: 0.7 mL/min):  
Daicel Chiralpak IA: t1 = 13.0 min  and  t2 = 15.5 min  
Daicel Chiralpak IB:  t1 = 9.4 min  and  t2 = 11.4 min 
Daicel Chiralpak AS-H: t1 = 8.7 min  and  t2 = 9.3 min 
Daicel Chiralcel OJ-H: t1 = 20.3 min  and  t2 = 22.7 min 
  
General procedure for the racemization of [2.2]metacyclophanes (heptane). In a round-bottom 
flask equipped with a reflux condenser, a sample of enantiopure [2.2]metacyclophane (0.5 mg) 
was dissolved in heptane (1 mL) and heated at reflux (373 K). At a specified time interval, a sample 
of 20 µL was taken and directly submitted for HPLC analysis. 
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General procedure for the racemization of [2.2]metacyclophanes (NMP). In a round-bottom flask 
equipped with a reflux condenser, a sample of enantiopure [2.2]metacyclophane (0.5 mg) was 
dissolved in N-methyl-2-pyrrolidone (1 mL) and heated at 453 K. At a specified time interval, a 
sample (approx vol. 100 µL) was taken and rapidly cooled to room temperature with an ice bath. 
Heptane (approx. vol. 0.5 mL) was added and, after a short micro extraction, the upper heptane 
layer was isolated and submitted for HPLC analysis. 
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1H, 2H and 13C NMR spectra for compounds 3, 3-D2, 5, 6, 8 and 9. X-Ray crystallographic data for 
6 and 8. Chiral semi-preparative HPLC resolution plots of 6 and 9 and racemization plots data.  
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